Noticias de ABT_US
Noticias del mercado
Últimas noticias sobre ABT_US — 735 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Abbott Laboratories acordó pagar 670 millones de dólares para resolver aproximadamente 2.000 demandas que alegaban que sus fórmulas a base de leche de vaca de uso hospitalario causaban necrosis...
Analyst Raises Abbott Price Target to $135 on Strengthening Cancer Diagnostics Growth and Successful Exact Sciences Integration
Las acciones de Abbott Laboratories están respaldadas por un ritmo del segundo trimestre de 2026, una orientación más alta y un precio de apertura de 114,16 dólares.
Asset Advisors Investment Management LLC trimmed its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 55.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 48,495 shares of the healthcar
Confluence Wealth Services Inc. raised its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 25.5% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 44,422 shares of the healthcare product mak
Exchange Traded Concepts LLC increased its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 31.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 75,528 shares of the healthcare produc
Financial & Tax Architects LLC increased its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 25.3% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 80,248 shares of the healthcare product maker
Capital Investment Advisory Services LLC decreased its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 44.2% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 15,546 shares of the healthcare product maker
ABN Amro Investment Solutions raised its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 21.1% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 111,702 shares of the healthcare product maker
Alecta Tjanstepension Omsesidigt lifted its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 10.5% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,609,200 shares of the healthcare product maker
Página 5 de 37